These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21671366)

  • 41. Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease.
    Schatz J; Finke R; Roberts CW
    J Dev Behav Pediatr; 2004 Oct; 25(5):303-10. PubMed ID: 15502546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes.
    King AA; White DA; McKinstry RC; Noetzel M; Debaun MR
    Neurology; 2007 Jun; 68(23):2008-11. PubMed ID: 17548550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Need for cognitive rehabilitation for children with sickle cell disease and strokes.
    King AA; DeBaun MR; White DA
    Expert Rev Neurother; 2008 Feb; 8(2):291-6. PubMed ID: 18271713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between somatic growth trajectory and cognitive functioning in young children with sickle cell disease.
    Puffer ES; Schatz JC; Roberts CW
    J Health Psychol; 2016 Aug; 21(8):1620-9. PubMed ID: 25488939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
    Berkelhammer LD; Williamson AL; Sanford SD; Dirksen CL; Sharp WG; Margulies AS; Prengler RA
    Child Neuropsychol; 2007 Mar; 13(2):120-31. PubMed ID: 17364569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective study of the relationship over time of behavior problems, intellectual functioning, and family functioning in children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease.
    Thompson RJ; Armstrong FD; Link CL; Pegelow CH; Moser F; Wang WC
    J Pediatr Psychol; 2003; 28(1):59-65. PubMed ID: 12490632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EXAMINER executive function battery and neurologic morbidity in pediatric sickle cell disease.
    Schatz J; Stancil M; Katz T; Sanchez CE
    J Int Neuropsychol Soc; 2014 Jan; 20(1):29-40. PubMed ID: 24280593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive aspects of pediatric sickle cell disease.
    Brown RT; Armstrong FD; Eckman JR
    J Learn Disabil; 1993 Jan; 26(1):33-45. PubMed ID: 8418188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Status epilepticus in a patient with sickle cell disease].
    Aguirre-Bermeo H; Millón J; Martínez-Domeño A; Marruecos-Sant L
    Med Clin (Barc); 2011 Oct; 137(9):428-9. PubMed ID: 21450316
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurocognitive complications of sickle cell anemia in adults.
    Ballas SK
    JAMA; 2010 May; 303(18):1862-3. PubMed ID: 20460628
    [No Abstract]   [Full Text] [Related]  

  • 51. Cognitive and behavioral function in children with sickle cell disease: a review and discussion of methodological issues.
    White DA; DeBaun M
    J Pediatr Hematol Oncol; 1998; 20(5):458-62. PubMed ID: 9787319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Examining the influence of pain and fatigue on neurocognitive functioning in adolescents and young adults with sickle cell disease.
    Semko JH; Longoria J; Porter J; Potter B; Bhatia S; Pan H; Hankins JS; Heitzer AM
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30621. PubMed ID: 37561401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
    Longoria JN; Heitzer AM; Hankins JS; Trpchevska A; Porter JS
    Br J Haematol; 2022 May; 197(3):260-270. PubMed ID: 35118643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.
    Iampietro M; Giovannetti T; Tarazi R
    Neuropsychol Rev; 2014 Jun; 24(2):252-65. PubMed ID: 24744195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Keep your heart healthy to help preserve communication skills. Cardiovascular disease, which can cause reduced blood flow, can affect how we understand and respond to spoken language.
    Duke Med Health News; 2011 Nov; 17(11):3. PubMed ID: 22211250
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease.
    Hardy RA; Rached NA; Jones JA; Archer DR; Hyacinth HI
    Exp Biol Med (Maywood); 2021 Jan; 246(1):106-120. PubMed ID: 32962408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paraneoplastic disorders of the memory and cognition: clinical aspects and therapeutic approaches.
    Dalmau J
    Handb Clin Neurol; 2008; 89():873-6. PubMed ID: 18631802
    [No Abstract]   [Full Text] [Related]  

  • 58. Patient with Gluten Encephalopathy Presenting with Neuropsychiatric Symptoms.
    Arshad I; Javeed A; Ullah U
    Am J Med; 2018 Feb; 131(2):e49-e50. PubMed ID: 29024626
    [No Abstract]   [Full Text] [Related]  

  • 59. "Severity" in adult sickle cell disease.
    Steinberg MH; Gladwin MT
    Am J Hematol; 2023 Oct; 98(10):1508-1511. PubMed ID: 37449407
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychopathology, psychopharmacology and the organic brain syndromes. Part I.
    Ban TA
    Psychosomatics; 1976; 17(2):77-82. PubMed ID: 940910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.